Linked Data API

Show Search Form

Search Results

1689180
star this property registered interest false more like this
star this property date less than 2024-02-16more like thismore than 2024-02-16
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Drugs: Shortages more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what comparative assessment she has made of trends in the total number of medicine shortages recorded by her Department in January (a) 2021, (b) 2022, (c) 2023 and (d) 2024. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 14113 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-27more like thismore than 2024-02-27
star this property answer text <p>There are around 14,000 licensed medicines, and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex and global, and supply disruption is a common issue which affects countries all around the world.</p><p>The Department’s medicine Discontinuations and Shortages portal has been collecting notifications from suppliers of potential supply issues since October 2020, and shows that there were approximately:</p><p>- 90 supply issue notifications in January 2021;</p><p>- 110 supply issue notifications in January 2022;</p><p>- 170 supply issue notifications in January 2023; and</p><p>- 160 supply issue notifications in January 2024.</p><p>Although reporting does vary each month, annual notifications have remained fairly stable at approximately 1,600 supply issue notifications in 2022 and 2023. It is important to note that not all supply issue notifications will lead to a medicine shortage.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-02-27T11:24:53.65Zmore like thismore than 2024-02-27T11:24:53.65Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1689181
star this property registered interest false more like this
star this property date less than 2024-02-16more like thismore than 2024-02-16
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Parkinson's Disease: Drugs more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions she has had with the Medicines and Healthcare products Regulatory Agency on the average licensing approval decision timelines for (a) generic and (b) biosimilar medicines to treat Parkinson's disease. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 14114 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-27more like thismore than 2024-02-27
star this property answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is taking urgent action to deliver improvements to decision timescales in established medicines, including those indicated to treat Parkinson’s disease. Last week we approved additional licences for this critical area. Whilst no specific discussions have taken place between the MHRA and my Rt hon. Friend, the Secretary of State for Health and Social Care on this matter, we are taking significant steps to assess applications for medicine approval within statutory timeframes and will always prioritise applications according to public health need.</p><p>We are working to reduce timelines by bringing in additional resources and developing processes that will result in significantly improved response times, while protecting patient safety. The measures we are putting in place are already resulting in significant improvements, and we will continue to publish monthly updates providing applicants with transparent information on expected timescales. As an effective regulator, we are committed to the highest of standards of performance and delivering the right outcomes for patients and public health.</p>
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property grouped question UIN 14115 more like this
star this property question first answered
less than 2024-02-27T11:32:52.23Zmore like thismore than 2024-02-27T11:32:52.23Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1689182
star this property registered interest false more like this
star this property date less than 2024-02-16more like thismore than 2024-02-16
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Parkinson's Disease: Drugs more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether she is taking steps with the Medicines and Healthcare products Regulatory Agency to reduce the time taken to license (a) generic and (b) biosimilar medicines to treat Parkinson's disease. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 14115 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-27more like thismore than 2024-02-27
star this property answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is taking urgent action to deliver improvements to decision timescales in established medicines, including those indicated to treat Parkinson’s disease. Last week we approved additional licences for this critical area. Whilst no specific discussions have taken place between the MHRA and my Rt hon. Friend, the Secretary of State for Health and Social Care on this matter, we are taking significant steps to assess applications for medicine approval within statutory timeframes and will always prioritise applications according to public health need.</p><p>We are working to reduce timelines by bringing in additional resources and developing processes that will result in significantly improved response times, while protecting patient safety. The measures we are putting in place are already resulting in significant improvements, and we will continue to publish monthly updates providing applicants with transparent information on expected timescales. As an effective regulator, we are committed to the highest of standards of performance and delivering the right outcomes for patients and public health.</p>
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property grouped question UIN 14114 more like this
star this property question first answered
less than 2024-02-27T11:32:52.277Zmore like thismore than 2024-02-27T11:32:52.277Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1685842
star this property registered interest false more like this
star this property date less than 2024-01-30more like thismore than 2024-01-30
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Drugs: Shortages more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps her Department is taking to tackle medicine shortages. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 12074 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-05more like thismore than 2024-02-05
star this property answer text <p>There are around 14,000 licensed medicines and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex, and global, meaning there can sometimes be supply issues which affect the United Kingdom, along with other countries around the world.</p><p>Medicine supply problems can occur for several reasons such as manufacturing difficulties, regulatory non-compliance, access to raw materials, sudden demand spikes or distribution issues.</p><p>While it is not always possible to prevent supply issues from occurring, there is a team within the Department that has a range of well-established tools and processes to manage them when they arise, working closely with the pharmaceutical industry, the National Health Service, the Medicines and Healthcare products Regulatory Agency and others operating in the supply chain to help mitigate the risks to patients.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-02-05T15:39:06.387Zmore like thismore than 2024-02-05T15:39:06.387Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property previous answer version
15319
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1683706
star this property registered interest false more like this
star this property date less than 2024-01-19more like thismore than 2024-01-19
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prescriptions: Fees and Charges more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the list of medical conditions which meet the criteria for a medical exemption certificate. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 10653 more like this
star this property answer
answer
star this property is ministerial correction true more like this
star this property date of answer less than 2024-01-26more like thismore than 2024-01-26
star this property answer text <p>Approximately 89% of prescriptions are dispensed free of charge. People on a low income who do not qualify for an exemption from prescription charges can seek help under the NHS Low Income Scheme, which provides help with health costs on an income-related basis. For those who do not qualify for an exemption, prescription prepayment certificates (PPCs) allow people to obtain as many prescriptions as they need for a set cost. A three-monthly PPC or an annual PPC will save people money if they need four or more items in three months or <ins class="ministerial">12</ins> <del class="ministerial">13</del> or more items in 12 months.</p> more like this
star this property answering member constituency South Northamptonshire more like this
star this property answering member printed Andrea Leadsom more like this
star this property question first answered
less than 2024-01-26T09:57:19.193Zmore like thismore than 2024-01-26T09:57:19.193Z
star this property question first ministerially corrected
less than 2024-02-01T15:51:08.21Zmore like thismore than 2024-02-01T15:51:08.21Z
star this property answering member
4117
star this property label Biography information for Andrea Leadsom more like this
star this property previous answer version
13571
star this property answering member constituency South Northamptonshire more like this
star this property answering member printed Andrea Leadsom more like this
star this property answering member
4117
star this property label Biography information for Andrea Leadsom more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1606002
star this property registered interest false more like this
star this property date less than 2023-03-21more like thismore than 2023-03-21
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Databases more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure data held on the proposed NHS Federated Data Platform is protected. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 170685 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-03-30more like thismore than 2023-03-30
star this property answer text <p>Data processes and systems within the Federated Data Platform (FDP) will need to comply with the Technology Code of Practice, Government Digital Service standards, the Department’s guide to good practice for digital and data-driven health technologies, the Data Protection Act 2018 and the United Kingdom’s General Data Protection Regulation, Information Commissioner’s Office guidance and associated regulations, standards and guidance.</p><p> </p><p>To ensure that the FDP complies, the data sharing approach will consist of: a Data Protection Impact Assessment (DPIA) for the procurement of the FDP solution; overarching DPIA to articulate the data security and protection principles and lawful bases for deployment; purpose-specific DPIAs, which will be drafted for each use case and will go through the formal approval routes within NHS England prior to roll-out; and a legal mechanism for the sharing and processing of data, to be agreed in consultation with NHS England Information Governance and legal counsel.</p><p /><p>The above activities will be concurrent and aligned with the procurement process to ensure data protection by design and default principles are embedded, and there is co-production of the final data sharing approach.  This will ensure that the lawful basis for the data sharing is identified, and Common Law Duty of Confidentiality is adhered to for all of the use cases.</p>
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property grouped question UIN 171540 more like this
star this property question first answered
less than 2023-03-30T15:12:24.02Zmore like thismore than 2023-03-30T15:12:24.02Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1586651
star this property registered interest false more like this
star this property date less than 2023-02-17more like thismore than 2023-02-17
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Cygnet Healthcare more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the average daily cost to the NHS was for a person receiving mental health support in a hospital ward owned by Cygnet Health Care in the latest period for which data is available. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 147363 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-02-22more like thismore than 2023-02-22
star this property answer text <p>The information requested is not held centrally.</p> more like this
star this property answering member constituency Lewes more like this
star this property answering member printed Maria Caulfield more like this
star this property question first answered
less than 2023-02-22T16:50:48.677Zmore like thismore than 2023-02-22T16:50:48.677Z
star this property answering member
4492
star this property label Biography information for Maria Caulfield more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1455467
star this property registered interest false more like this
star this property date less than 2022-03-29more like thismore than 2022-03-29
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Diagnosis more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the time taken to diagnose sarcoma cancer. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 149333 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-04-04more like thismore than 2022-04-04
star this property answer text <p>The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ details how the National Health Service will reduce the time taken to diagnose cancer, including sarcoma cancer. The plan aims to return the number of people waiting more than 62 days from an urgent referral for cancer to pre-pandemic levels by March 2023. By March 2024, 75% of patients who have been urgently referred by their general practitioner (GP) for suspected cancer will be diagnosed or have cancer ruled out within 28 days.</p><p>The NHS is raising awareness of cancer symptoms through the ‘Help us help you’ campaign and locally tailored approaches to increase the number of referrals from GPs. We are investing £2.3 billion to establish up to 160 community diagnostic centres (CDCs) by March 2025. CDCs will provide additional capacity for tests which can assist the diagnosis of sarcoma cancer, such as ultrasounds, magnetic resonance imaging and biopsies. Since July 2021, existing CDCs have provided over 650,000 additional tests.</p><p>Those diagnosed with sarcoma and with a family history or risk factors can access genomic tests to aid early diagnosis and treatment options. There are also specialist soft tissue sarcoma cancer centres and specialist bone sarcoma centres in England. These centres accept referrals for patients with suspected diagnoses from genomics results or primary or acute care.</p>
star this property answering member constituency Lewes more like this
star this property answering member printed Maria Caulfield more like this
star this property grouped question UIN 149334 more like this
star this property question first answered
less than 2022-04-04T12:22:43.897Zmore like thismore than 2022-04-04T12:22:43.897Z
star this property answering member
4492
star this property label Biography information for Maria Caulfield more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1455468
star this property registered interest false more like this
star this property date less than 2022-03-29more like thismore than 2022-03-29
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Diagnosis more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans he has to reduce the time taken to diagnose sarcoma cancer. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 149334 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-04-04more like thismore than 2022-04-04
star this property answer text <p>The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ details how the National Health Service will reduce the time taken to diagnose cancer, including sarcoma cancer. The plan aims to return the number of people waiting more than 62 days from an urgent referral for cancer to pre-pandemic levels by March 2023. By March 2024, 75% of patients who have been urgently referred by their general practitioner (GP) for suspected cancer will be diagnosed or have cancer ruled out within 28 days.</p><p>The NHS is raising awareness of cancer symptoms through the ‘Help us help you’ campaign and locally tailored approaches to increase the number of referrals from GPs. We are investing £2.3 billion to establish up to 160 community diagnostic centres (CDCs) by March 2025. CDCs will provide additional capacity for tests which can assist the diagnosis of sarcoma cancer, such as ultrasounds, magnetic resonance imaging and biopsies. Since July 2021, existing CDCs have provided over 650,000 additional tests.</p><p>Those diagnosed with sarcoma and with a family history or risk factors can access genomic tests to aid early diagnosis and treatment options. There are also specialist soft tissue sarcoma cancer centres and specialist bone sarcoma centres in England. These centres accept referrals for patients with suspected diagnoses from genomics results or primary or acute care.</p>
star this property answering member constituency Lewes more like this
star this property answering member printed Maria Caulfield more like this
star this property grouped question UIN 149333 more like this
star this property question first answered
less than 2022-04-04T12:22:43.943Zmore like thismore than 2022-04-04T12:22:43.943Z
star this property answering member
4492
star this property label Biography information for Maria Caulfield more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1455469
star this property registered interest false more like this
star this property date less than 2022-03-29more like thismore than 2022-03-29
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer more like this
unstar this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what his strategy is for increasing public awareness of sarcoma cancer. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi remove filter
star this property uin 149335 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-04-06more like thismore than 2022-04-06
star this property answer text <p>The ‘Help us help you’ encourages more people to consult their general practitioner if they experience symptoms which could be a sign of cancer. The current phase of the campaign focuses on the barriers to seeking advice, such as fear or anxiety, rather than on specific set symptoms. Previous phases of the campaign have included symptoms which could be indicative of sarcoma, such as abdominal discomfort or a persistent cough.</p><p>NHS England and NHS Improvement are committed to improving the completeness of staging data. The NHS England and NHS Improvement’s cancer programme is working with the National Disease Registration Service to identify trusts and tumour sites where staging data requires improvement.</p> more like this
star this property answering member constituency Lewes more like this
star this property answering member printed Maria Caulfield more like this
star this property grouped question UIN 149336 more like this
star this property question first answered
less than 2022-04-06T10:47:46.077Zmore like thismore than 2022-04-06T10:47:46.077Z
star this property answering member
4492
star this property label Biography information for Maria Caulfield more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this